Why Fastly Shares Are Popping Off

Fastly Inc (NASDAQ: FSLY) shares are trading higher by 11.5% to $8.81 Thursday after the company reported better-than-expected third-quarter EPS and sales results and issued FY22 sales guidance above estimates. What Happened?

Fastly Inc (NASDAQ:FSLY) shares are trading higher by 11.5% to $8.81 Thursday after the company reported better-than-expected third-quarter EPS and sales results and issued FY22 sales guidance above estimates.

What Happened?

Fastly reported quarterly losses of 14 cents per share which beat the analyst consensus estimate of a loss of 17 cents by 17.65 percent.

The company reported quarterly sales of $108.50 million which beat the analyst consensus estimate of $103.46 million by 5%. This is a 25% increase over sales of $86.73 million in the same period last year.

Fastly also sees fourth-quarter EPS in the range of a loss of 15 cents to a loss of 11 cents, which is greater than the analyst consensus estimate of 10 cents.

See Also: Why Alphabet Shares Hit A New 52-Week Low Today

Fastly sees fourth-quarter sales as low as $112 million or as high as $116 million, versus the analyst consensus estimate of $113.2 million.

Fastly sees FY22 EPS in the range of a loss of 67 cents to a loss of 63 cents, versus the analyst consensus estimate of a loss of 65 cents. 

FY22 sales are meanwhile expected in the range of $425 million to $429 million, versus the analyst consensus estimate of $419.75 million.

According to data from Benzinga Pro, Fastly has a 52-week high of $58.62 and a 52-week low of $7.32.

Total
0
Shares
Related Posts
Read More

Jaguar Health Shares Move Higher; Co’s Subsidiary Napo Pharmaceuticals Signs License Agreement With Italian Subsidiary, Napo EU S.p.A., To Develop And Commercialize Crofelemer And Lechlemer In Europe

Napo Pharmaceuticals, Inc. (Napo), the wholly owned US subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX), today announced the signing of a license agreement with Napo's Italian subsidiary, Napo EU S.p.A., to study,

JAGX